Literature DB >> 23375959

Progressive multifocal leukoencephalopathy in an immunocompetent patient.

Panos G Christakis1, Daniel Okin, Anita J Huttner, Joachim M Baehring.   

Abstract

A 69-year old man presents with a subacute history of worsening confusion, anxiety and abnormal gait. Brain MRI revealed an extensive non-enhancing signal abnormality of parieto-occipito-temporal white matter. CSF PCR was positive for JC virus, suggestive of progressive multifocal leukoencephalopathy (PML). Extensive workup for occult immunosuppression was negative. Although PML in an immunocompetent patient is exceedingly rare, biopsy confirmed the diagnosis. Mirtazapine and mefloquine therapies were initiated and JCV DNA titre decreased by 100-fold at six months. One year later, his clinical course had stabilized and neuroimaging was improved. Our case suggests that PML can rarely afflict immunocompetent individuals and that serotonin receptor targeting pharmacological therapy may improve the outcome.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375959     DOI: 10.1016/j.jns.2013.01.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

2.  A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients.

Authors:  Duško Kozić; Mladen Bjelan; Jasmina Boban; Jelena Ostojić; Vesna Turkulov; Aleksandar Todorović; Slobodanka Lemajić-Komazec; Snežana Brkić
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

3.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.

Authors:  Rebekka Kurmann; Christian Weisstanner; Piotr Kardas; Hans H Hirsch; Roland Wiest; Bernhard Lämmle; Hansjakob Furrer; Renaud Du Pasquier; Claudio L Bassetti; Mathias Sturzenegger; Heinz Krestel
Journal:  J Neurovirol       Date:  2015-04-28       Impact factor: 2.643

Review 4.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

5.  Progressive multifocal leukoencephalopathy in the absence of immunosuppression.

Authors:  Benjamin E Zucker; Sybil R L Stacpoole
Journal:  J Neurovirol       Date:  2017-11-14       Impact factor: 2.643

6.  Cerebellar Involvement in an Immunocompetent Patient Presenting with Progressive Multifocal Leukoencephalopathy.

Authors:  Rafael Garcia-Carretero; Blanca San Jose Montano
Journal:  Case Rep Neurol Med       Date:  2017-08-24

7.  Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.

Authors:  Lea Krey; Peter Raab; Romilda Sherzay; Georg Berding; Matthias Stoll; Martin Stangel; Florian Wegner
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

Review 8.  The Use of Antimalarial Drugs against Viral Infection.

Authors:  Sarah D'Alessandro; Diletta Scaccabarozzi; Lucia Signorini; Federica Perego; Denise P Ilboudo; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2020-01-08

9.  Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient.

Authors:  T Nanda
Journal:  Case Rep Neurol Med       Date:  2016-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.